Jan 06, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.19 to $0.01.
The split itself did not change the total investment value.
Aytu BioPharma, Inc. (AYTU) trades on the NASDAQ Capital Market in the Drug Manufacturers - Specialty & Generic industry.
Aytu BioPharma, Inc. company overviewThe latest split shown was on January 6, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 7 reverse splits between June 10, 2015 and January 6, 2023.